Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasey L Couts

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Melanoma Management|November 24, 2015
Understanding melanoma stem cellsNicholas Nguyen, Kasey L Couts, Yuchun Luo, et al.
Journal of Leukocyte Biology|October 14, 2023
Dysfunctional states of unconventional T-cell subsets in cancerElizabeth N Katsnelson, Andrea Spengler, Joanne Domenico, et al.
JCO Precision Oncology|February 17, 2022
Acral Lentiginous Melanoma Harboring a <i>ROS1</i> Gene Fusion With Clinical Response to EntrectinibKasey L Couts, Caroline E McCoach, Danielle Murphy, et al.
Metabolites|January 27, 2026
Profiling Serum Oxylipin Metabolites Across Melanoma Subtypes and Immunotherapy RespondersAlexander C Goodman, Kylie M Michel, Morgan L MacBeth, et al.
Journal of Surgical Oncology|October 28, 2024
Metastatic Melanoma to the Small Bowel and Colon: A Systematic Review of the Global Experience and Institutional Cohort Analysis Detailing a Rare Clinical EntityElliott J Yee, Otto N Thielen, Ronald Truong, et al.
The British Journal of Dermatology|March 4, 2025
Congenital melanocytic nevi initiated by BRAF fusion oncogene with firmness, pruritus, and desmoplastic stromaSimon F Roy, Nnenna G Agim, Adnan Mir, et al.
Melanoma Research|November 6, 2020
Clinical and molecular features of subungual melanomas are site-specific and distinct from acral melanomasBlair N Holman, Robert J Van Gulick, Carol M Amato, et al.
Frontiers in Immunology|July 3, 2026
Targeting liver metastases in uveal melanoma: ATX-LPA mediated immunosuppression and novel therapeutic approachesJacqueline A Turner, Marc D'Antonio, Heather N Montane, et al.
JAMA Network Open|December 13, 2022
Analysis of Human Leukocyte Antigen DR Alleles, Immune-Related Adverse Events, and Survival Associated With Immune Checkpoint Inhibitor Use Among Patients With Advanced Malignant MelanomaHalis Kaan Akturk, Kasey L Couts, Erin E Baschal, et al.
Cell Death & Disease|March 8, 2024
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockadeNabanita Mukherjee, Elizabeth Katsnelson, Tonya M Brunetti, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Melanoma Management|November 24, 2015
Understanding melanoma stem cellsNicholas Nguyen, Kasey L Couts, Yuchun Luo, et al.
Journal of Leukocyte Biology|October 14, 2023
Dysfunctional states of unconventional T-cell subsets in cancerElizabeth N Katsnelson, Andrea Spengler, Joanne Domenico, et al.
JCO Precision Oncology|February 17, 2022
Acral Lentiginous Melanoma Harboring a <i>ROS1</i> Gene Fusion With Clinical Response to EntrectinibKasey L Couts, Caroline E McCoach, Danielle Murphy, et al.
Metabolites|January 27, 2026
Profiling Serum Oxylipin Metabolites Across Melanoma Subtypes and Immunotherapy RespondersAlexander C Goodman, Kylie M Michel, Morgan L MacBeth, et al.
Journal of Surgical Oncology|October 28, 2024
Metastatic Melanoma to the Small Bowel and Colon: A Systematic Review of the Global Experience and Institutional Cohort Analysis Detailing a Rare Clinical EntityElliott J Yee, Otto N Thielen, Ronald Truong, et al.
The British Journal of Dermatology|March 4, 2025
Congenital melanocytic nevi initiated by BRAF fusion oncogene with firmness, pruritus, and desmoplastic stromaSimon F Roy, Nnenna G Agim, Adnan Mir, et al.
Melanoma Research|November 6, 2020
Clinical and molecular features of subungual melanomas are site-specific and distinct from acral melanomasBlair N Holman, Robert J Van Gulick, Carol M Amato, et al.
Frontiers in Immunology|July 3, 2026
Targeting liver metastases in uveal melanoma: ATX-LPA mediated immunosuppression and novel therapeutic approachesJacqueline A Turner, Marc D'Antonio, Heather N Montane, et al.
JAMA Network Open|December 13, 2022
Analysis of Human Leukocyte Antigen DR Alleles, Immune-Related Adverse Events, and Survival Associated With Immune Checkpoint Inhibitor Use Among Patients With Advanced Malignant MelanomaHalis Kaan Akturk, Kasey L Couts, Erin E Baschal, et al.
Cell Death & Disease|March 8, 2024
MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockadeNabanita Mukherjee, Elizabeth Katsnelson, Tonya M Brunetti, et al.
Pageof 4